Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis (gMG)

Explore clinical trials studying Generalized Myasthenia Gravis (gMG). Study availability and eligibility vary by location and protocol.

10 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis (gMG) trial results

Recruiting

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

NCT07294170

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Erlanger Health System Columbia, Maryland, United States
View all 29 locations
View Trial Details
Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

NCT07284420

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Henry Ford Health Systems Detroit, Michigan, United States
View all 24 locations
View Trial Details
Recruiting

A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

NCT07595653

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +12 more
Locations
  • Ospedale Generale Regionale F. Miulli Acquaviva delle Fonti, Italy
  • Azienda Ospedaliero Universitaria delle Marche Ancona, Italy
  • A.O.U. Consorziale Policlinico Bari, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
View all 30 locations
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details
Active, Not Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

NCT06359041

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis, Department of Neurology Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details

Related conditions